9th HBV Cure Workshop supported by ANRS | Emerging Infectious Diseases
by
3266 3266 people viewed this event.
The 9th HBV Cure Workshop, organized by ANRS | EID, will take place on Tuesday, July 5, 2022. This year, the meeting will be organized in Lyon, France and online.
Learn more about the event here
Program
9:30 am – 9:45 am Welcome
Yazdan Yazdanpanah (Director of ANRS) & Fabien Zoulim (ANRS HBV cure Task Force)
9:45 am – 11:15 am Session I: Clinical trials
Chairs: Hélène Fontaine & Jean-Michel Pawlotsky
- Clinical development of direct acting antivirals for chronic hepatitis B – MF Yuen (Hong Kong)
- Clinical development of immune therapies for chronic hepatitis B –Harry Janssen (Rotterdam, the Netherlands)
- Emerging therapies for chronic hepatitis Delta –Marc Bourlière (Marseille, France)
Roundtable discussion: what will be the best combination strategies ?
11:15 am – 11:30 am Coffee Break
11:30 am – 1:00 pm Session II: Immune responses
Chairs: David Durantel & Hélène Strick-Marchand
- New advances in the immunobiology of HBV infection –Matteo Iannacone (Milan, Italy)
- Novel therapeutic vaccines in development – Robert Thimme (Freiburg, Germany) Digital
- Mechanisms of HBV-HDV interference – Julie Lucifora (Lyon, France)
Roundtable discussion
1:00 pm – 2:00 pm Lunch Break
2:00 pm – 3:30 pm Session III: Virology
Chairs: Michael Kann & Patrick Soussan
- cccDNA formation and DNA repair processes –Alexander Ploss (Princeton, USA)
- Crosstalk between HBV and the 3D Genome –Christine Neuveut (Montpellier, France)
- Targeting HBV cccDNA persistence by gene editing approaches –Barbara Testoni (Lyon, France)
Roundtable discussion
3:30 pm – 3:45 pm Tea & Coffee Break
3:45 pm – 5:35 pm Session IV: Assessing the liver reservoir
Chairs: Massimo Levrero & Vincent Leroy
- cccDNA quantification for the investigation of new therapies –Lena Allweiss (Hamburg, Germany)
- HBV integration and new HBV-associated drivers of hepatocarcinogenesis –Jean-Charles Nault (Paris, France)
- Assessment of the intrahepatic immune responses –Adam Gehring (Toronto, Canada)
- Non invasive biomarkers to monitor the cccDNA reservoir –Sofia Perez del Pulgar (Barcelona, Spain)
Roundtable discussion : fine needle aspirates or peripheral biomarkers ?
5.35 pm – 6.00 pm Session V: Roundtable discussion
Chairs: Harry Janssen & Sofia Perez del Pulgar
- What are the remaining key challenges to cure HBV and HDV ? (contributors TBD)
6:00 pm Farewell – Fabien Zoulim
6.00 pm – 7.00 pm Get together cocktail